Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T08:13:46.716Z Has data issue: false hasContentIssue false
  • English
  • Français

Biobank Regulation in South Korea

Published online by Cambridge University Press:  01 January 2021

Won Bok Lee
Get access Rights & Permissions [Opens in a new window]

Abstract

Like many other countries, South Korea has recognized the importance of biobanks as a tool for medical research and has engaged in two very important tasks to foster biobanking infrastructure: funding biobanks and setting up rules to protect the integrity of biobanks that share potentially sensitive personal information.

Type
Independent Articles
Information
Journal of Law, Medicine & Ethics , Volume 44 , Issue 2: Ethical and Legal Issues in Pediatrics , Summer 2016 , pp. 342 - 351
Copyright
Copyright © American Society of Law, Medicine and Ethics 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

This piece of legislation is also translated as “The Bioethics and Safety Act.” In this article, “The Bioethics and Biosafety Act” is used instead, which is a more accurate representation of the contents of the law.Google Scholar
For critique on the inaugural legislation of the Bioethics and Biosafety Act from various ethical perspectives, see Kim, J.H., “An Analysis on ‘Bioethics and Biosafety Act,’” Journal of the Korea Bioethics Association 5, no.1 (2004): 1–11; Kim, J.H. et al., “A Critical Analysis of The ‘Bioethics & Biosafety Act,’” Korean Journal of Medical Ethics Education 8, no.1 (2005): 21–33.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 1.Google Scholar
Korean Constitutional Court, 2005HunMa346, May 27, 2010. The case was dismissed by the Korean Constitutional Court.Google Scholar
Bioethics and Biosafety Act of 2005, Art. 5.Google Scholar
Jhalani, M., “Protecting Egg Donors and Human Embryos — The Failure of the South Korean Bioethics and Biosafety Act,” Pacific Rim Law & Policy Journal 17 (2008): 707–34. Prof. Hwang also participated in fabricating an article on stem cells published in Nature, which was later retracted. D. Cyranoski, “Verdict: Hwang's Human Stem Cells Were All Fakes,” Nature 439, no.7073 (2006): 122–23. For those interested in learning more about this convoluted story, see Kim, T.H., “How Could a Scientist Become a National Celebrity? Nationalism and Hwang Woo-Suk Scandal,” East Asian Science, Technology and Society 2, no.1 (2008): 27–45.Google Scholar
For a synopsis of the 2012 amendment and its critique, see e.g., Park, S.H., “Korean Regulations of Clinical Trials and Research with Human Subjects,” Biomedical Law & Ethics 6, no.1 (2012): 1–18; Cho, H.S., “The System, Contents and Problems on New Bioethics and Safety Act,” Public Law Journal 13, no. 4 (2012): 251–68; Kim, E.A., “A Study on the Proposed Amendment Bill of Bioethics and Safety Law: Focusing on the Meaning of Significant Contents Related to the Clinical Research,” Korean Society of Law and Medicine 12, no.1 (2011): 99–131.Google Scholar
The Bioethics and Biosafety Act of 2012 makes it manifestly clear that now protection of human research subjects is one of its most important goals. For example, Art. 3, which was inserted in 2012, reads as follows:Google Scholar
While Korea's regulatory framework for biobanking is pretty robust, there is one unmistakable idiosyncrasy about the law. Cord blood is governed under a separate piece of legislation. For reasons that are not entirely clear from a policy perspective, cord blood samples are regulated by the Cord Blood Management and Research Act.Google Scholar
Knoppers, B. M., “Biobanking: International Norms,” Journal of Law, Medicine & Ethics 33, no. 1 (2005): 7-14.CrossRefGoogle Scholar
Bioethics and Biosafety Act of Korea, Chapter V, Section 1, Art. 36-40.Google Scholar
Bioethics and Biosafety Act of Korea, Chapter V, Section 2, Art. 41-45.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 2, Item 17.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 2, Item 18.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 2, Item 14.Google Scholar
The Bioethics and Biosafety Act of Korea actually employs the term “anonymization” categorically to include both of the two methods of de-identification. This article, however, will use the term “de-identification” categorically, and reserve the word “anonymization” for the irreversible removal of personally identifiable information. Such usage was advocated in Knoppers, B.M., “Biobanking: International Norms,” Journal of Law, Medicine & Ethics 33, no. 1 (2005): 7-14.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 2, Item 19.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 10, Para. 1.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 13.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 14.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 10, Para. 3.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 3, Para 6.Google Scholar
Chang, Y. J. and Kong, S. Y., “Legal and Ethical Use of Biospecimens in Research Following Major Revision of the Bioethics and Safety Act,” Laboratory Medicine Online 5, no. 3 (2015): 113–20.Google Scholar
See, e.g., Korean Constitutional Court, 99HunMa513, 2004HunMa190, May 25, 2005. For a critique on the Korean Constitutional Court's decision in this regard, see Jung, H.S., “Critical Analysis on the Korean Constitutional Court”s Decisions Concerning the Right to Informational Self-Determination,” Pusan National University Law Review 56, no. 4 (2015): 1–31.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 37.Google Scholar
Minister's Decree under the Bioethics and Biosafety Act of Korea, Schedule 34.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 37, Para. 3.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 70.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 39, Para. 1.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 39, Para. 1.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 36, Para. 1.Google Scholar
Minister's Decree under the Bioethics and Biosafety Act of Korea, Art. 33, Para. 1.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 41, Para. 1, 2.Google Scholar
At least 1 information manager and two biobank researchers must be hired by a biobank.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 41, Para. 4.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 45.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 42.Google Scholar
Minister's Decree under the Bioethics and Biosafety Act of Korea, Schedule 41.Google Scholar
Grady, C. et al., “Broad Consent for Research With Biological Samples: Workshop Conclusions,” American Journal of Bioethics 15, no. 9 (2015): 34–42.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 44, Para. 4.Google Scholar
Minister's Decree under the Bioethics and Biosafety Act of Korea, Art. 42, Para. 1.Google Scholar
Minister's Decree under the Bioethics and Biosafety Act of Korea, Art. 42, Para. 2.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 43, Para. 2.Google Scholar
Ministry of Health and Welfare of Korea, Standard Operation Guidelines for Biobanks (2013): at 91-92.Google Scholar
Ministry of Health and Welfare of Korea, Standard Operation Guidelines for Biobanks (2013): at 92-96.Google Scholar
Minister's Decree under the Bioethics and Biosafety Act of Korea, Art. 41, Para. 1.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 43, Para. 1.Google Scholar
Bioethics and Biosafety Act of Korea, Art. 43, Para 4.Google Scholar
Minister's Decree under the Bioethics and Biosafety Act of Korea, Art. 41, Para 3.Google Scholar
Ministry of Health and Welfare of Korea, Standard Operation Guidelines for Biobanks (2013), at 100.Google Scholar
Ministry of Health and Welfare of Korea, Standard Operation Guidelines for Biobanks (2013), at 99.Google Scholar
Ministry of Health and Welfare of Korea, Standard Operation Guidelines for Biobanks (2013): at 99.Google Scholar
Cho, S. Y. et al., “Opening of the National Biobank of Korea as the Infrastructure of Future Biomedical Science in Korea,” Osong Public Health and Research Perspectives 3, no. 3 (2012): 177-84.Google Scholar
Id.Google Scholar
Park, O. et al., “A Strategic Plan for the Second Phase (2013–2015) of the Korea Biobank Project,” Osong Public Health and Research Perspectives 4, no. 2 (2013): 107-16.Google Scholar
S.Y. Cho et al., supra note 53, at 180–181.Google Scholar
Lee, J.E. et al., “National Biobank of Korea: Quality Control Programs of Collected-Human Biospecimens,” Osong Public Health and Research Perspectives 3, no. 3 (2012): 185-89.Google Scholar
Korean Center for Disease Control, “Korea Biobank Network statistics,” available at <http://www.cdc.go.kr/CDC/contents/CdcKrContentView.jsp?cid=61463&menuIds=HOME001MNU1136-MNU1826-MNU1831-MNU1874> (last visited March 1, 2016)+(last+visited+March+1,+2016)>Google Scholar
O. Park et al., supra note 55, at 110–111.Google Scholar
O. Park et al., supra note 55, at 111.Google Scholar
E.g., Gymrek, M. et al., “Identifying Personal Genomes by Surname Inference,” Science 339, no. 6117 (2013): 321-24.CrossRefGoogle Scholar
Cho, S. Y. et al., “Opening of the National Biobank of Korea as the Infrastructure of Future Biomedical Science in Korea,” Osong Public Health and Research Perspectives 3, no. 3 (2012): 177-84, at 181. Requests for sharing serum samples came in a distant second with 8%, followed by plasma at 3%.CrossRefGoogle Scholar
Grady, C. et al., “Broad Consent for Research With Biological Samples: Workshop Conclusions,” American Journal of Bioethics 15, no. 9 (2015): 34-42.Google Scholar
Kim, E. A., “Significance and Limitation of Recent Changes in the Wholly Amended Bioethics and Safety Act for the Protection of the Human Research Participant,” Journal of the Korea Bioethics Association 15, no. 2 (2014): 15-35.Google Scholar
Rothstein, M. A., Knoppers, B. M., and Harrell, H. L., “Comparative Approaches to Biobanks and Privacy,” Journal of Law, Medicine and Ethics 44, no. 1 (2016): 161-172.Google Scholar
Yan, S. and Kwon, K. J., “Massive data theft hits 40% of South Koreans,” CNN Money International, January 21, 2014, available at <http://money.cnn.com/2014/01/21/technology/koreadata-hack/> (last visited March 1, 2016).+(last+visited+March+1,+2016).>Google Scholar
“Credit card firms ordered to compensate consumers for data leak,” The Korea Herald, January 22, 2016, available at <http://www.koreaherald.com/view.php?ud=20160122000543> (last visited March 1, 2016) (the court awarded mere $83 to each victim of personal information breach).+(last+visited+March+1,+2016)+(the+court+awarded+mere+$83+to+each+victim+of+personal+information+breach).>Google Scholar
Koo, H. G. and Rha, J. Y., “An Exploratory Study on Consumer Perception of Giving Consent for Personal Information,” Journal of Consumption Culture 17 (2014): 151-181 (“Although the right to consent is not only the basic human right but also the property right, many consumers don't pay enough attention to the consent process and the terms of privacy policy…[m]any consumers don't read the terms of privacy policy…”)Google Scholar
For example, the maximum sentence for implanting a cloned human embryo is 10 years in prison. The maximum sentence for fertilizing an egg for a purpose other than actual pregnancy is 3 years in prison. The maximum sentence for collecting human egg or sperm without written consent is 2 years in prison.Google Scholar